Perisinusoidal lipocytes and fibrogenesis.

Por Gressner, A M
Publicado em 1994

Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-β as major players and therapeutic targets

Por Gressner, A M, Weiskirchen, R
Publicado em 2006

De novo expression of glutamine synthetase during transformation of hepatic stellate cells into myofibroblast-like cells.

Por Bode, J G, Peters-Regehr, T, Gressner, A M, Häussinger, D
Publicado em 1998

Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblastlike cells. A potential mechanism of self perpetuation in liver fibrogenes...

Por Bachem, M G, Meyer, D, Melchior, R, Sell, K M, Gressner, A M
Publicado em 1992

LIM-domain protein cysteine- and glycine-rich protein 2 (CRP2) is a novel marker of hepatic stellate cells and binding partner of the protein inhibitor of activated STAT1.

Por Weiskirchen, R, Moser, M, Weiskirchen, S, Erdel, M, Dahmen, S, Buettner, R, Gressner, A M
Publicado em 2001

Thrombospondin 1 acts as a strong promoter of transforming growth factor β effects via two distinct mechanisms in hepatic stellate cells

Por Breitkopf, K, Sawitza, I, Westhoff, J H, Wickert, L, Dooley, S, Gressner, A M
Publicado em 2005

Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis.

Por Herbst, H., Wege, T., Milani, S., Pellegrini, G., Orzechowski, H. D., Bechstein, W. O., Neuhaus, P., Gressner, A. M., Schuppan, D.
Publicado em 1997

Liver fibrogenesis due to cholestasis is associated with increased Smad7 expression and Smad3 signaling

Por Seyhan, H, Hamzavi, J, Wiercinska, Eliza, Gressner, A M, Mertens, P R, Kopp, J, Horch, R E, Breitkopf, Katja, Dooley, S
Publicado em 2006